AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evolution of Masticatory Function, Orofacial Functions and Quality of Life of Patients Treated for Cancers of the Upper Aerodigestive Tract, Rehabilitated by Maxillofacial Prostheses.

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Clermont-Ferrand
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a follow-up study of masticatory function, orofacial functions, and quality of life in patients with a history of upper aerodigestive tract cancer who have undergone rehabilitation with maxillofacial prostheses. The main objective of this study is to evaluate changes in masticatory function during a prosthetic rehabilitation program in patients with a history of upper aerodigestive tract cancer.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adult patient who has given their consent * Patient with a history of upper aerodigestive tract cancer * Cooperative patient * Patient affiliated with a Social Security scheme * Patient capable of understanding and participating in the study * Patient not allergic to the foods being tested Exclusion Criteria: * Minors * Patients treated in the maxillofacial prosthetics clinic of the Odontology Department at Estaing University Hospital in Clermont Ferrand who do not require prosthetic rehabilitation * Patients who are unwilling to participate in the study, particularly in attending the various follow-up sessions * Patients who do not have a good command of written and spoken French * Patients under guardianship, curatorship, or judicial protection * Pregnant or breastfeeding patients * Patients receiving enteral or parenteral nutrition * Patients who have been diagnosed with a recurrence of their cancer and whose prognosis is life-threatening. * Patients with cognitive impairment
๐Ÿ’Š

What it tests

  • Prosthetic oral rehabilitation
๐Ÿ“

Where

1 site
CHU de Clermont-Fd
Clermont-Ferrand, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy